Euroapi Company Header Euroapi Company Header

X

CAS 106261-64-7 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 106261-64-7
Also known as: 106261-64-7, 4-((4-methylpiperazin-1-yl)methyl)benzoyl chloride dihydrochloride, 4-[(4-methylpiperazin-1-yl)methyl]benzoyl chloride;dihydrochloride, 4-[(4-methylpiperazin-1-yl)methyl]benzoyl chloride dihydrochloride, Mfcd11519983, 4-((4-methylpiperazin-1-yl)methyl)benzoyl chloride 2hcl
Molecular Formula
C13H19Cl3N2O
Molecular Weight
325.7  g/mol
InChI Key
DDKLQZDSVJKYLJ-UHFFFAOYSA-N

1 2D Structure

CAS 106261-64-7

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(4-methylpiperazin-1-yl)methyl]benzoyl chloride;dihydrochloride
2.1.2 InChI
InChI=1S/C13H17ClN2O.2ClH/c1-15-6-8-16(9-7-15)10-11-2-4-12(5-3-11)13(14)17;;/h2-5H,6-10H2,1H3;2*1H
2.1.3 InChI Key
DDKLQZDSVJKYLJ-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1CCN(CC1)CC2=CC=C(C=C2)C(=O)Cl.Cl.Cl
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 106261-64-7

2. 4-((4-methylpiperazin-1-yl)methyl)benzoyl Chloride Dihydrochloride

3. 4-[(4-methylpiperazin-1-yl)methyl]benzoyl Chloride;dihydrochloride

4. 4-[(4-methylpiperazin-1-yl)methyl]benzoyl Chloride Dihydrochloride

5. Mfcd11519983

6. 4-((4-methylpiperazin-1-yl)methyl)benzoyl Chloride 2hcl

7. Benzoyl Chloride, 4-[(4-methyl-1-piperazinyl)methyl]-, Dihydrochloride

8. 4-(4-methylpiperazin-1-ylmethyl)benzoyl Chloride Dihydrochloride

9. 4-[(4-methyl-1-piperazinyl)methyl]benzoyl Chloride Dihydrochloride

10. Schembl529195

11. Dtxsid10603844

12. Amy22082

13. 4-[(4-methylpiperazin-1-yl)methyl]benzoyl Chloride,dihydrochloride

14. 4-[(4-methylpiperazin-1-yl)methyl]benzoyl Chloride--hydrogen Chloride (1/2)

15. Akos015909677

16. Ac-23930

17. As-39950

18. Sy245383

19. Ft-0658811

20. 261m647

21. A801429

22. A851421

23. A1-03413

24. 4-(4-methylpiperazinylmethyl)benzoyl Chloride 2hcl

25. 4-(4-methylpiperazinylmethyl)benzoyl-chloride Dihydrochloride

26. 4-(4-methylpiperzin-1-ylmethyl)benzoyl Chloride Dihydrochloride

27. 4-(4-methylpiperazin-1-yl-methyl)benzoyl Chloride Dihydrochloride

28. 4-[(4-methyl-1-piperazinyl)methyl]benzoyl Chloride, Dihydrochloride

2.3 Create Date
2007-12-05
3 Chemical and Physical Properties
Molecular Weight 325.7 g/mol
Molecular Formula C13H19Cl3N2O
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Exact Mass324.056296 g/mol
Monoisotopic Mass324.056296 g/mol
Topological Polar Surface Area23.6 Ų
Heavy Atom Count19
Formal Charge0
Complexity256
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
Flag India
Digital Content Digital Content
URL Supplier Web Content
350-03-8
Imatinib Mesylate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
152460-10-1
Imatinib Mesylate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
106261-49-8
Imatinib Mesylate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag India
Digital Content Digital Content
URL Supplier Web Content
55314-16-4
Imatinib Mesylate
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderaba...
Ocimum Labs was founded in 2018 and started its R&D activities with a cutting-edge facility. The Hyderabad-based firm focuses on process research and development, with a particular emphasis on choosing an API portfolio with a wide range of applications for the global pharma market. It provides a wide variety of integrated products and services. By offering timely and high-quality support, Ocimum Labs hopes to become a strategic partner to global pharma firms and deliver high-quality, cost effective key starting materials, intermediates and APIs. It intends to build a manufacturing facility with a 230KL capacity in Visakhapatnam, India.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY